SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bhag Karamchandani who wrote (110)1/29/1997 11:29:00 AM
From: aknahow   of 305
 
Bhag, I had the same question. However in the call it was made clear why repeat test needed. Past test were done on 750 mg.& 4 doses. This test also included new lower dose 250 given more times over longer period. (8 times over 2 1/2 wks). So now they must repeat test to confirm results of the 250 cc? mg? procedure. I share your thoughts spoken or unspoken.-g-. Was supprised market apparently saw news as all positive. I had thought that the requirment for 8 injections rather thab 4 was a big deal (negative) but now believe its not given the info of how long current treatment takes. Forgot to post that these treatments don't give lifetime immunity. Must repeat seasonally. "Cat". may provide longer period of relief but this has not yet been demonstrated.

Please remember as an investor not a scientist this post is based on what I thought I heard. I do try to think of the implications of what is being said. The cost/profit factor of lower dose proceedure may offset some of negatives once a product is launched if container size reduction compensates for more vials.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext